Previous close | 1.3200 |
Open | 1.3200 |
Bid | 0.0000 |
Ask | 1.9500 |
Strike | 7.50 |
Expiry date | 2024-11-15 |
Day's range | 1.3200 - 1.3200 |
Contract range | N/A |
Volume | |
Open interest | 9 |
On June 10, 2024, Julie Mchugh, Director at Ironwood Pharmaceuticals Inc (NASDAQ:IRWD), executed a sale of 22,766 shares of the company.
On June 7, 2024, Catherine Moukheibir, a Director at Ironwood Pharmaceuticals Inc (NASDAQ:IRWD), executed a sale of 80,000 shares of the company.
BOSTON, May 30, 2024--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that Sravan Emany, Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 9:00 a.m. ET at the Marriott Marquis in New York City.